Relative Conspicuity of Gadolinium-Based Contrast Agents in Interventional Pain Procedures

Timothy Maus, Beth A. Schueler, Dixon J. Magnuson, Dayne Magnuson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To assess the relative radiographic conspicuity of gadolinium-based contrast agents (GBCAs) that may be used in spinal injection procedures when iodine-based contrast agents are contraindicated.

Methods: Eight GBCAs and three iodinated agents of varying iodine concentrations were radiographed under conditions representative of lumbar spinal injections at four kilovoltage peak (kVp) values. Radiographic contrast of each agent was measured as the percent pixel value difference with respect to background.

Results: Gadobutrol (Gadovist, 1 mM/mL) had the highest radiographic contrast among the gadolinium agents tested. Measured radiographic contrast correlated with the molar concentration of gadolinium. Gadobutrol radiographic contrast lies between the contrast of iohexol concentrations of 240 and 140 mgI/mL. All agents have decreasing contrast as kVp increases, but GBCAs decrease less than iodine-based agents.

Conclusions: Gadobutrol is the GBCA with the greatest conspicuity for use in spinal injection procedures. It also has the highest molar concentration of gadolinium, and potential neural toxicity from intrathecal delivery must be considered.

Original languageEnglish (US)
Pages (from-to)651-654
Number of pages4
JournalPain medicine (Malden, Mass.)
Volume18
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Gadolinium
Contrast Media
Pain
Spinal Injections
Iodine
Iohexol
gadobutrol

Keywords

  • contrast allergy
  • Contrast media
  • epidural
  • gadolinium

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Relative Conspicuity of Gadolinium-Based Contrast Agents in Interventional Pain Procedures. / Maus, Timothy; Schueler, Beth A.; Magnuson, Dixon J.; Magnuson, Dayne.

In: Pain medicine (Malden, Mass.), Vol. 18, No. 4, 01.04.2017, p. 651-654.

Research output: Contribution to journalArticle

Maus, Timothy ; Schueler, Beth A. ; Magnuson, Dixon J. ; Magnuson, Dayne. / Relative Conspicuity of Gadolinium-Based Contrast Agents in Interventional Pain Procedures. In: Pain medicine (Malden, Mass.). 2017 ; Vol. 18, No. 4. pp. 651-654.
@article{8d8af7c6f9ba477bb9b3a4a172463cfd,
title = "Relative Conspicuity of Gadolinium-Based Contrast Agents in Interventional Pain Procedures",
abstract = "Objective: To assess the relative radiographic conspicuity of gadolinium-based contrast agents (GBCAs) that may be used in spinal injection procedures when iodine-based contrast agents are contraindicated.Methods: Eight GBCAs and three iodinated agents of varying iodine concentrations were radiographed under conditions representative of lumbar spinal injections at four kilovoltage peak (kVp) values. Radiographic contrast of each agent was measured as the percent pixel value difference with respect to background.Results: Gadobutrol (Gadovist, 1 mM/mL) had the highest radiographic contrast among the gadolinium agents tested. Measured radiographic contrast correlated with the molar concentration of gadolinium. Gadobutrol radiographic contrast lies between the contrast of iohexol concentrations of 240 and 140 mgI/mL. All agents have decreasing contrast as kVp increases, but GBCAs decrease less than iodine-based agents.Conclusions: Gadobutrol is the GBCA with the greatest conspicuity for use in spinal injection procedures. It also has the highest molar concentration of gadolinium, and potential neural toxicity from intrathecal delivery must be considered.",
keywords = "contrast allergy, Contrast media, epidural, gadolinium",
author = "Timothy Maus and Schueler, {Beth A.} and Magnuson, {Dixon J.} and Dayne Magnuson",
year = "2017",
month = "4",
day = "1",
doi = "10.1093/pm/pnw312",
language = "English (US)",
volume = "18",
pages = "651--654",
journal = "Pain Medicine",
issn = "1526-2375",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Relative Conspicuity of Gadolinium-Based Contrast Agents in Interventional Pain Procedures

AU - Maus, Timothy

AU - Schueler, Beth A.

AU - Magnuson, Dixon J.

AU - Magnuson, Dayne

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Objective: To assess the relative radiographic conspicuity of gadolinium-based contrast agents (GBCAs) that may be used in spinal injection procedures when iodine-based contrast agents are contraindicated.Methods: Eight GBCAs and three iodinated agents of varying iodine concentrations were radiographed under conditions representative of lumbar spinal injections at four kilovoltage peak (kVp) values. Radiographic contrast of each agent was measured as the percent pixel value difference with respect to background.Results: Gadobutrol (Gadovist, 1 mM/mL) had the highest radiographic contrast among the gadolinium agents tested. Measured radiographic contrast correlated with the molar concentration of gadolinium. Gadobutrol radiographic contrast lies between the contrast of iohexol concentrations of 240 and 140 mgI/mL. All agents have decreasing contrast as kVp increases, but GBCAs decrease less than iodine-based agents.Conclusions: Gadobutrol is the GBCA with the greatest conspicuity for use in spinal injection procedures. It also has the highest molar concentration of gadolinium, and potential neural toxicity from intrathecal delivery must be considered.

AB - Objective: To assess the relative radiographic conspicuity of gadolinium-based contrast agents (GBCAs) that may be used in spinal injection procedures when iodine-based contrast agents are contraindicated.Methods: Eight GBCAs and three iodinated agents of varying iodine concentrations were radiographed under conditions representative of lumbar spinal injections at four kilovoltage peak (kVp) values. Radiographic contrast of each agent was measured as the percent pixel value difference with respect to background.Results: Gadobutrol (Gadovist, 1 mM/mL) had the highest radiographic contrast among the gadolinium agents tested. Measured radiographic contrast correlated with the molar concentration of gadolinium. Gadobutrol radiographic contrast lies between the contrast of iohexol concentrations of 240 and 140 mgI/mL. All agents have decreasing contrast as kVp increases, but GBCAs decrease less than iodine-based agents.Conclusions: Gadobutrol is the GBCA with the greatest conspicuity for use in spinal injection procedures. It also has the highest molar concentration of gadolinium, and potential neural toxicity from intrathecal delivery must be considered.

KW - contrast allergy

KW - Contrast media

KW - epidural

KW - gadolinium

UR - http://www.scopus.com/inward/record.url?scp=85044146390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044146390&partnerID=8YFLogxK

U2 - 10.1093/pm/pnw312

DO - 10.1093/pm/pnw312

M3 - Article

C2 - 28586445

AN - SCOPUS:85044146390

VL - 18

SP - 651

EP - 654

JO - Pain Medicine

JF - Pain Medicine

SN - 1526-2375

IS - 4

ER -